Hypoxia-alleviated nanoplatform to enhance chemosensitivity and sonodynamic effect in pancreatic cancer

Ultrasound-Switchable Nanozyme Augments Sonodynamic Therapy against Multidrug-Resistant Bacterial Infection

(2020) Duo Sun et al.   ACS Nano

ROS-augmented and tumor-microenvironment responsive biodegradable nanoplatform for enhancing chemo-sonodynamic therapy

(2020) Jie An et al.   BIOMATERIALS

Low-Dose Gemcitabine Treatment Enhances Immunogenicity and Natural Killer Cell-Driven Tumor Immunity in Lung Cancer

(2020) Xin Zhang et al.   Frontiers in Immunology

Hypoxia and pancreatic ductal adenocarcinoma

(2020) Akio Yamasaki et al.   CANCER LETTERS

Hypoxia in tumor microenvironment regulates exosome biogenesis: Molecular mechanisms and translational opportunities

(2020) Ashish Kumar et al.   CANCER LETTERS

Recent advances in strategies for overcoming hypoxia in photodynamic therapy of cancer

(2020) Barbara Pucelik et al.   CANCER LETTERS

Low‑intensity low‑frequency ultrasound enhances the chemosensitivity of gemcitabine‑resistant ASPC‑1 cells via PI3K/AKT/NF‑κB pathway‑mediated ABC transporters

(2020) Fuqiang Qiu et al.   ONCOLOGY REPORTS

Microfluidics-Assisted Surface Trifunctionalization of a Zeolitic Imidazolate Framework Nanocarrier for Targeted and Controllable Multitherapies of Tumors

(2020) Jie Shen et al.   ACS Applied Materials & Interfaces

Hypoxia-responsive nanoparticles for tumor-targeted drug delivery

(2020) Yuce Li et al.   CANCER LETTERS

Hypoxia-induced epithelial to mesenchymal transition in cancer

(2020) Robert Y. Hapke et al.   CANCER LETTERS

Nanotechnology improves the therapeutic efficacy of gemcitabine against a human hepatocellular carcinoma cell line and minimizes its in vivo side effects

(2020) Sawsan M. A. El-Sheikh et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Microbubble-Mediated Cavitation Promotes Apoptosis and Suppresses Invasion in AsPC-1 Cells

(2020) Jing Cao et al.   ULTRASOUND IN MEDICINE AND BIOLOGY

Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy

(2019) Qian Chen et al.   ADVANCED MATERIALS

Chemotherapy for pancreatic cancer

(2019) Christoph Springfeld et al.   PRESSE MEDICALE

Dual ATP and pH responsive ZIF-90 nanosystem with favorable biocompatibility and facile post-modification improves therapeutic outcomes of triple negative breast cancer in vivo

(2019) Zhenqi Jiang et al.   BIOMATERIALS

Intelligent Hollow Pt-CuS Janus Architecture for Synergistic Catalysis-Enhanced Sonodynamic and Photothermal Cancer Therapy

(2019) Shuang Liang et al.   NANO LETTERS

Schiff-base reaction induced selective sensing of trace dopamine based on a Pt41Rh59 alloy/ZIF-90 nanocomposite

(2019) Wei Chen et al.   NANOTECHNOLOGY

Role of hypoxia in cancer therapy by regulating the tumor microenvironment

(2019) Xinming Jing et al.   Molecular Cancer

Gemcitabine loaded autologous exosomes for effective and safe chemotherapy of pancreatic cancer

(2019) Yong-Jiang Li et al.   Acta Biomaterialia

Tumor Microenvironment-Responsive Mesoporous MnO2 -Coated Upconversion Nanoplatform for Self-Enhanced Tumor Theranostics

(2018) Jiating Xu et al.   ADVANCED FUNCTIONAL MATERIALS

Antitumor effect of gemcitabine-loaded albumin nanoparticle on gemcitabine-resistant pancreatic cancer induced by low hENT1 expression

(2018) Zhongyi Guo et al.   International Journal of Nanomedicine

IR780 loaded perfluorohexane nanodroplets for efficient sonodynamic effect induced by short-pulsed focused ultrasound

(2018) Nan Chang et al.   ULTRASONICS SONOCHEMISTRY

Gemcitabine plus cisplatin versus gemcitabine alone in the treatment of pancreatic cancer: a meta-analysis

(2016) Guoqing Ouyang et al.   World Journal of Surgical Oncology

Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity

(2015) Hiroshi Maeda   ADVANCED DRUG DELIVERY REVIEWS

Crystals as Molecules: Postsynthesis Covalent Functionalization of Zeolitic Imidazolate Frameworks

(2008) William Morris et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY